Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 765092

Effects of glucagon-like peptide-1 receptor agonist liraglutide on blood pressure and heart rate in overweight type 2 diabetic patients


Bulum, Tomislav; Blaslov, Kristina; Prkačin, Ingrid; Zibar, Karin; Duvnjak, Lea
Effects of glucagon-like peptide-1 receptor agonist liraglutide on blood pressure and heart rate in overweight type 2 diabetic patients // Journal of Hypertension 2015 ; 33 (e-Suppl. 1): e299-e300
Milano, Italija, 2015. (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 765092 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Effects of glucagon-like peptide-1 receptor agonist liraglutide on blood pressure and heart rate in overweight type 2 diabetic patients

Autori
Bulum, Tomislav ; Blaslov, Kristina ; Prkačin, Ingrid ; Zibar, Karin ; Duvnjak, Lea

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Journal of Hypertension 2015 ; 33 (e-Suppl. 1): e299-e300 / - , 2015

Skup
25th European Meeting on Hypertension

Mjesto i datum
Milano, Italija, 12.06.2015. - 15.06.2015

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
glucagon-like peptide-1; blood pressure; heart rate

Sažetak
Glucagon-lik epeptide-1 (GLP-1) agonists are increasingly used in the management of type 2 diabetes mellitus(T2DM), but their long-term cardiovascular safety is not yet confirmed. In the present study, we assessed effects of liraglutide on systolic blood pressure(SBP), diastolic blood pressure(DBP)and HR in overweight T2DM. The results of our study suggest that therapy with GLP-1 receptor agonist liraglutide may significantly reduce SBP and DBP by 6 to 10 mmHg and may offer an alternative therapy for hypertension in overweight T2DM. In addition, in our study therapy with liraglutide was associated with a small decrease in HR.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Medicinski fakultet, Zagreb


Citiraj ovu publikaciju:

Bulum, Tomislav; Blaslov, Kristina; Prkačin, Ingrid; Zibar, Karin; Duvnjak, Lea
Effects of glucagon-like peptide-1 receptor agonist liraglutide on blood pressure and heart rate in overweight type 2 diabetic patients // Journal of Hypertension 2015 ; 33 (e-Suppl. 1): e299-e300
Milano, Italija, 2015. (poster, međunarodna recenzija, sažetak, znanstveni)
Bulum, T., Blaslov, K., Prkačin, I., Zibar, K. & Duvnjak, L. (2015) Effects of glucagon-like peptide-1 receptor agonist liraglutide on blood pressure and heart rate in overweight type 2 diabetic patients. U: Journal of Hypertension 2015 ; 33 (e-Suppl. 1): e299-e300.
@article{article, author = {Bulum, Tomislav and Blaslov, Kristina and Prka\v{c}in, Ingrid and Zibar, Karin and Duvnjak, Lea}, year = {2015}, keywords = {glucagon-like peptide-1, blood pressure, heart rate}, title = {Effects of glucagon-like peptide-1 receptor agonist liraglutide on blood pressure and heart rate in overweight type 2 diabetic patients}, keyword = {glucagon-like peptide-1, blood pressure, heart rate}, publisherplace = {Milano, Italija} }
@article{article, author = {Bulum, Tomislav and Blaslov, Kristina and Prka\v{c}in, Ingrid and Zibar, Karin and Duvnjak, Lea}, year = {2015}, keywords = {glucagon-like peptide-1, blood pressure, heart rate}, title = {Effects of glucagon-like peptide-1 receptor agonist liraglutide on blood pressure and heart rate in overweight type 2 diabetic patients}, keyword = {glucagon-like peptide-1, blood pressure, heart rate}, publisherplace = {Milano, Italija} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font